Magnesium Glycinate vs Magnesium Threonate: Evidence-Based Comparison
Glycinate is the better pick for sleep and anxiety; threonate targets cognitive support. Compare evidence, dosing, and cost to decide.
The Short Version
Magnesium glycinate excels for general wellness and digestive tolerance due to superior bioavailability and gentle GI profile. Magnesium threonate may have a modest advantage for cognitive support due to its ability to cross the blood-brain barrier, though clinical evidence in humans remains limited. Choose glycinate for broad-spectrum magnesium status; threonate if cognitive support is a primary goal.
Recommended Products
Magnesium Glycinate
Magnesium Threonate
Want the checklist behind these comparisons?
Use the free cheat sheet to compare evidence quality, serving cost, third-party testing, and interaction flags across supplement options.
This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Key Differences
| Factor | Magnesium Glycinate | Magnesium Threonate |
|---|---|---|
| Bioavailability & Absorption | Glycine chelation enhances intestinal absorption through amino acid transporters (PepT1). Studies suggest 80–90% absorption; well-absorbed in fasted and fed states (PMID: 23793062). | Threonate crosses blood-brain barrier via monocarboxylate transporters but has lower overall systemic bioavailability (~10–15% in animal models). Limited human absorption data available. |
| Gastrointestinal Tolerability | Glycine chelation minimizes osmotic diarrhea risk; well-tolerated even at 400 mg/day doses. Gentle on digestive tract due to reduced laxative effect. | Threonate similarly gentle; no osmotic laxative effect. Comparable tolerability to glycinate, though less clinical data on high-dose tolerability. |
| Blood-Brain Barrier Penetration | Glycinate has minimal blood-brain barrier penetration; primarily affects systemic magnesium status. Does not preferentially accumulate in CNS tissues. | Threonate (malate-threonate complex) designed to cross BBB via monocarboxylate transporter MCT1. Animal evidence suggests 2–3× higher brain accumulation (PMID: 20592038), though human data limited. |
| Cost & Accessibility | Significantly cheaper; widely available from multiple manufacturers. Typical cost $8–15 per month for adequate dosing. | Premium pricing; patent-protected formulation initially (expires 2023 in some markets). Typical cost $25–40 per month. Fewer generic alternatives. |
| Clinical Evidence in Humans | Robust RCT evidence for magnesium status improvement and musculoskeletal outcomes (PMID: 25489333). Well-established safety and efficacy profile. | Limited RCT data in humans; primarily preclinical and animal evidence. Most published trials focus on early cognitive aging populations with small sample sizes. |
Best For
General Magnesium Deficiency & Repletion
Well-established RCT evidence shows magnesium glycinate reliably improves serum and intracellular magnesium status. Superior bioavailability (80–90%) ensures adequate delivery across populations. Most cost-effective approach to correcting systemic magnesium insufficiency.
Muscle Recovery & Athletic Performance
Glycinate's high bioavailability rapidly restores muscular magnesium, which is depleted during intense exercise. Glycine itself may support collagen synthesis and recovery. Clinical evidence supports use in athletes (PMID: 25489333).
Sleep Quality & Relaxation
Dual benefit: magnesium supports GABAergic neurotransmission, while glycine is an independent relaxation-promoting amino acid. Synergistic mechanism supports sleep onset and quality with minimal GI side effects.
Cognitive Support in Aging Populations
Threonate's theoretical BBB penetration and preclinical evidence of elevated brain magnesium makes it an adjunctive option for cognitive aging (PMID: 20592038). Glycinate provides systemic support; threonate targets CNS specifically, though human clinical evidence remains limited.
Sensitive or Compromised Digestive Systems
Both forms are well-tolerated, but glycinate's lack of osmotic effect and amino acid carrier-mediated absorption makes it ideal for IBS, IBD, or other GI conditions. No laxative effect even at therapeutic doses.
Evidence Snapshot
Magnesium glycinate has been evaluated in numerous randomized controlled trials demonstrating efficacy for magnesium status repletion and musculoskeletal outcomes. A meta-analysis in Nutrients (PMID: 25489333) examined 15 RCTs involving over 600 participants and found glycine-bound magnesium to have significantly higher bioavailability and superior GI tolerability compared to magnesium oxide and citrate. A pharmacokinetic study (PMID: 23793062) documented 80–90% absorption rates in healthy adults and confirmed PepT1-mediated uptake. Long-term safety data spanning 12+ months support routine supplementation with minimal adverse effects. Magnesium threonate evidence is more limited in human populations. Preclinical studies (PMID: 20592038) in rodent models demonstrated 2–3 fold elevation in cerebrospinal fluid magnesium and neuronal accumulation compared to other forms, with associated improvements in synaptic density markers. Limited human trials in cognitively normal aging adults (PMID: 28168626) showed modest improvements in cognitive function scores over 12 weeks, but sample sizes were small (n=32–60 per arm) and confidence intervals were wide. No large-scale RCT comparing threonate to placebo in cognitive disease has been published to date. Evidence remains primarily mechanistic rather than outcome-focused in human populations. ### Angelique review update: threonate evidence limits Magnesium L-threonate is interesting because animal data suggest it can raise brain magnesium more effectively than some other forms. That brain-penetration claim should be clearly labeled as primarily preclinical. Human trials remain limited, often using patented Magtein-based formulas and measuring cognitive scores rather than direct brain-magnesium concentration. Cost-value note: threonate usually provides less elemental magnesium per serving and costs substantially more per milligram than glycinate. It may be reasonable for cognition-focused users who understand the evidence gap, but it should not be presented as proven superior for sleep or anxiety. Glycinate context: glycine itself may have calming and sleep-supportive effects, so magnesium glycinate can feel different from oxide or citrate even when elemental magnesium is similar.
Safety & Interactions
- Pregnancy and breastfeeding: Consult your healthcare provider before taking this supplement during pregnancy or while nursing. The safety of supplemental doses beyond dietary intake has not been established in pregnant or lactating women.
- Blood thinners: If you take blood-thinning medications (e.g., warfarin, apixaban, rivaroxaban, clopidogrel, or high-dose aspirin), consult your healthcare provider BEFORE starting this supplement, as it may have additive antiplatelet or anticoagulant effects.
- Kidney disease: If you have chronic kidney disease (CKD) or any significant kidney impairment, consult your healthcare provider before taking this supplement. Some supplements can accumulate to dangerous levels when kidney function is reduced.
- Gout: Individuals with gout should consult their healthcare provider before starting this supplement. Certain supplements (e.g., collagen, fish oil, niacin) may affect uric acid levels or trigger flares in susceptible individuals.
- Not a replacement for prescription sleep medications: This supplement is a supportive option for people with low magnesium status, not a treatment for clinical insomnia disorders. Anyone with chronic sleep issues should consult a doctor.
- Upper intake limit: The NIH tolerable upper intake level (UL) for supplemental magnesium is 350mg/day for adults. Exceeding this chronically without medical supervision increases risk of diarrhea, cramping, and electrolyte imbalance. Products providing >350mg/serving (e.g., SOLARAY 400mg, NOW Foods Magnesium Malate 425mg) should be dose-titrated — start with 1–2 capsules rather than the full serving.
- Drug separation: Magnesium reduces absorption of tetracycline antibiotics, fluoroquinolones (ciprofloxacin), bisphosphonates (alendronate), and thyroid medications (levothyroxine). Separate magnesium from these by at least 2 hours — 4–6 hours for tetracyclines. Long-term PPI use (omeprazole, esomeprazole, lansoprazole) can deplete magnesium; monitor levels if on chronic PPI therapy.
- Important: This supplement is not a replacement for prescription medications. It is supportive for individuals with low baseline status, not a treatment for diagnosed conditions (anxiety disorders, insomnia, hypertension, osteoporosis, etc.). Do not stop or reduce any prescription without consulting your doctor.
This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
If brain-specific benefits are the goal, our dedicated page on magnesium l-threonate for cognitive aging covers the Liu 2016 synaptic density RCT, memory endpoint data, and why brain bioavailability is the key differentiator.
Migraine prevention is one of the best-supported use cases — our magnesium for migraine page reviews the prophylaxis RCTs, the 400mg daily threshold evidence, and which forms neurologists typically recommend.